Stay updated on Elotuzumab in Myeloma: VRD Induction Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab in Myeloma: VRD Induction Clinical Trial page.

Latest updates to the Elotuzumab in Myeloma: VRD Induction Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe study record history now includes a new revision entry (v3.3.2) and the previous revision (v3.3.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now shows a new revision entry v3.3.1 and the v3.2.0 entry was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved a site-wide notice about a lapse in government funding that warned information may not be up to date and that operations could be affected. This deletion does not change the trial record history or data displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check65 days agoChange DetectedThe new screenshot shows a slightly different UI layout for the History page, while the version entries and dates remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference12%

Stay in the know with updates to Elotuzumab in Myeloma: VRD Induction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab in Myeloma: VRD Induction Clinical Trial page.